Dongying Chen, Yanyan Sun, Xiaowu Li, Zongyi Yin
Department of Anesthesia, Shenzhen University General Hospital, Shenzhen University, Shenzhen, China.
Department of Hepatobiliary Surgery, Shenzhen University General Hospital, Shenzhen University, Shenzhen, China.
Front Public Health. 2025 Jul 28;13:1550518. doi: 10.3389/fpubh.2025.1550518. eCollection 2025.
Drug use disorders (DUDs) continue to pose a heavy burden on individuals, families, and societies. Despite extensive research, there remains a paucity of comprehensive reports on the spatiotemporal distribution, driving factors, and future trends of DUDs at global, regional, and national levels. This study aims to address this gap by investigating these critical aspects of the DUDs epidemic.
Annual data on DUDs-related burden were collected from the Global Burden of Diseases, injuries, and risk factors Study (GBD) 2021. Age-period-cohort (APC) analysis and estimated annual percentage change were used to evaluate the spatiotemporal trend of burden. Decomposition analysis was used to identify the temporal and population-specific variations in the burden. The slope index of inequality and the concentration index were utilized to summarize health inequality of the burden. Frontier analysis was performed to evaluate the relationship between the burden of DUDs and socio-demographic development. The Nordpred model and Bayesian age-period-cohort (BAPC) model were introduced to forecast the burden. In 2021, the global prevalence of DUDs reached 53,115,936 (95% UI: 46,999,805-60,949,054), marking a 35.50% increase since 1990 and is projected to continue rising over the next 25 years. The increment in incidence, deaths, and disability-adjusted life years (DALYs) was 35.50%, 122.22%, and 74.65%, respectively. Despite the declining trends in global rates of incidence, prevalence, and DALYs, mortality still shows an upward trend, increasing from 1.26 to 1.65 per 100,000. Opioid and cocaine use disorders were the primary contributors to the overall increase in DUDs DALYs (82.07 and 59.57%, respectively). Population growth was the primary driver of the increase in DUDs DALYs (35.31%). A higher burden was observed in males and populations aged 15-39 years. Health inequality and insufficient healthcare performance regarding DUDs remain prominent issues in both high and low socio-demographic index (SDI) regions.
This study underscores the persistent and evolving nature of DUDs. Future research should focus on understanding the complex interplay between age and gender disparities, socioeconomic development, drug policies, and DUDs burden to inform more effective global strategies.
药物使用障碍(DUDs)继续给个人、家庭和社会带来沉重负担。尽管进行了广泛研究,但在全球、区域和国家层面,关于DUDs的时空分布、驱动因素和未来趋势的综合报告仍然匮乏。本研究旨在通过调查DUDs流行的这些关键方面来填补这一空白。
从《2021年全球疾病、伤害和风险因素负担研究》(GBD 2021)中收集了与DUDs相关负担的年度数据。采用年龄-时期-队列(APC)分析和估计的年百分比变化来评估负担的时空趋势。分解分析用于确定负担的时间和特定人群差异。利用不平等斜率指数和集中指数来总结负担的健康不平等情况。进行前沿分析以评估DUDs负担与社会人口发展之间的关系。引入Nordpred模型和贝叶斯年龄-时期-队列(BAPC)模型来预测负担。2021年,全球DUDs患病率达到53115936例(95%不确定区间:46999805 - 60949054例),自1990年以来增长了35.50%,预计在未来25年将继续上升。发病率、死亡人数和伤残调整生命年(DALYs)的增量分别为35.50%、122.22%和74.65%。尽管全球发病率、患病率和DALYs率呈下降趋势,但死亡率仍呈上升趋势,从每10万人1.26例增至1.65例。阿片类药物和可卡因使用障碍是DUDs DALYs总体增加的主要原因(分别为82.07%和59.57%)。人口增长是DUDs DALYs增加的主要驱动因素(35.31%)。在男性和15 - 39岁人群中观察到更高的负担。在社会人口指数(SDI)高和低的地区,关于DUDs的健康不平等和医疗保健绩效不足仍然是突出问题。
本研究强调了DUDs的持续性和演变性。未来的研究应侧重于理解年龄和性别差异、社会经济发展、药物政策与DUDs负担之间的复杂相互作用,以为更有效的全球战略提供信息。